CAMBRIDGE, Mass. -- (Business Wire)
Please replace the release with the following corrected version due to
multiple revisions.
The corrected release reads:
BIOGEN IDEC TO REPORT FOURTH QUARTER AND YEAR END 2014 FINANCIAL
RESULTS ON JANUARY 29, 2015
Biogen Idec Inc. (NASDAQ:BIIB) today announced that due to the severe
blizzard that is expected to impact the Northeast through Wednesday
morning, and the declared state of emergency, the Company has
rescheduled its Fourth Quarter and Year End 2014 earnings release to
Thursday, January 29, 2015, after the financial markets close.
Following the release of the financials, the Company will host a live
webcast where Biogen Idec management will discuss the financial results,
at 4:30 pm ET. To access the live webcast, please go to the investor
relations section of Biogen Idec’s website at www.biogenidec.com.
Following the live webcast, an archived version of the call will be
available at the same URL, for one month.
About Biogen Idec
Through cutting-edge science and medicine, Biogen Idec discovers,
develops and delivers to patients worldwide innovative therapies for the
treatment of neurodegenerative diseases, hemophilia and autoimmune
disorders. Founded in 1978, Biogen Idec is the world’s oldest
independent biotechnology company. Patients worldwide benefit from its
leading multiple sclerosis therapies. For product labeling, press
releases and additional information about the company, please visit www.biogenidec.com.
Contacts:
Biogen Idec
Karen Jewell, 781-464-2442
Investor Relations
Source: Biogen Idec
© 2024 Canjex Publishing Ltd. All rights reserved.